FDA Approved: DESONIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

The FDA approved a supplemental application for DESONIDE submitted by Padagis Israel Pharmaceuticals Ltd, resulting in labeling changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis

Drugs mentioned

• Desonide (Desonide)

Snippet

SUPPL AP for DESONIDE (DESONIDE)